$JCAP

Jefferson Capital, Inc. / DE

Insider trades
1
0
0

No SEC Form 4 filings for $JCAP in the last 30 days.

See all $JCAP insider activity →
Med

Jefferson Capital, Inc. / DE (JCAP): Results of Operations and Financial Condition

Jefferson Capital, Inc. / DE (JCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 jcap-20260813xex99d1.htm EX-99.1 ​ Exhibit 99.1 ​ Jefferson Capital Reports Second Quarter 2026 Results ​ Collections Grow 18% to $300.9 Million and Deployments grow 21% to $152.2 Million Estimated Remaining Collections (“ERC”) up 18% to $3.4 Billion Pre-tax Income of $

Jefferson Capital, Inc. / DE (JCAP): Submission of Matters to a Vote of Security Holders

Jefferson Capital, Inc. / DE (JCAP) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0002046042 Jefferson Capital, Inc. / DE 0002046042 2026-06-05 2026-06-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHA

JCAP sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning JCAP (Jefferson Capital, Inc. / DE). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent JCAP coverage spans financial news, earnings and corporate actions.

What's driving JCAP

  • Q2 operating metrics and profitability (pre-tax and net income) plus capital/liquidity updates (RCF upsized, notes repayment deposit) can drive near-term sentiment and positioning.

    SEC EDGAR 8-K · Aug 13, 2026

  • Board and auditor ratification are routine governance updates; they may slightly affect governance risk perception but do not change fundamentals on their own.

    SEC EDGAR 8-K · Jun 8, 2026

  • Jefferson Capital's Q1 adjusted EPS of $0.73 surpasses estimates, signaling strong financial performance.

    marketscreener.com · May 15, 2026

  • Jefferson Capital reported record Q1 2026 collections and revenue, driven by strategic acquisitions and deployment growth. The company's emphasis on varied consumer credit segments and maintained operational efficiency suggests a stable outlook. The bullish sentiment indicates potential upside, but elevated consumer delinquencies pose some risks.

    Benzinga · May 15, 2026

  • Jefferson Capital Inc is expected to report earnings of 69 cents per share, indicating moderate positive financial performance. This could lead to a short-term stock price increase, especially if results meet or exceed expectations.

    TradingView · May 13, 2026

alphai scores every news story that mentions JCAP with an AI model for sentiment and relevance, and aggregates insider trades from Jefferson Capital, Inc. / DE's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $JCAP

Score
$JCAPMed

Jefferson Capital, Inc. / DE (JCAP): Results of Operations and Financial Condition

Jefferson Capital, Inc. / DE (JCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 jcap-20260813xex99d1.htm EX-99.1 ​ Exhibit 99.1 ​ Jefferson Capital Reports Second Quarter 2026 Results ​ Collections Grow 18% to $300.9 Million and Deployments grow 21% to $152.2 Million Estimated Remaining Collections (“ERC”) up 18% to $3.4 Billion Pre-tax Income of $

Jefferson Capital, Inc. / DE (JCAP): Submission of Matters to a Vote of Security Holders

Jefferson Capital, Inc. / DE (JCAP) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0002046042 Jefferson Capital, Inc. / DE 0002046042 2026-06-05 2026-06-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHA

$JCAPMed

Transcript: Jefferson Capital Q1 2026 Earnings Conference Call

Jefferson Capital reported record Q1 2026 collections of $310 million and revenue of $176 million, driven by strong deployments and strategic acquisitions like Bluestem and Conn's portfolios. The company emphasized its strategic advantage in varied consumer credit segments, including auto finance and insolvency, amidst elevated consumer delinquencies and strong liquidity. Management expressed confidence in future portfolio supply and maintained a focus on operating efficiency, legal channel collections, and attractive shareholder returns.

$JCAPMed

Jefferson Capital (JCAP) lifts revolving credit commitments to $1,150,000,000

Jefferson Capital, Inc. (JCAP) has increased its aggregate revolving credit commitments by $150,000,000, bringing the total to $1,150,000,000 through Amendment No. 8 to its Credit Agreement. This amendment also raises the maximum cap on future incremental increases to $1,425,000,000, allowing for additional potential increases of up to $275,000,000. Aside from these changes to the revolving credit capacity, the underlying Credit Agreement remains substantially the same.

$JCAPLow

Jefferson Capital (JCAP) director discloses stock option positions

Jefferson Capital, Inc. director Susan E. Atkins has disclosed her initial beneficial ownership, detailing two direct stock option positions for a total of 50,000 common shares. These options have exercise prices of $20.1300 and $34.1300, both expiring on March 17, 2036, and vest in three equal annual installments contingent on her continued service. No stock purchases or sales were reported in this Form 3 filing.

Jefferson Capital stockholders to sell 10 million shares in secondary offering

Jefferson Capital (NASDAQ:JCAP) announced a secondary offering where existing stockholders will sell 10 million shares, with an option for underwriters to purchase an additional 1.5 million shares. The company plans to repurchase and retire 3 million shares from the underwriters, while all proceeds from the offering will go to the selling stockholders. This follows a recent acquisition of credit card assets and positive analyst outlooks, reflecting strong financial health and growth potential for Jefferson Capital.

Related tickers